跳到正文
原文
Medical Xpress·· 2026-10-02AI 评分45

PNAS 研究:质谱技术可在 3 分钟内映射脑肿瘤边缘

Mass spectrometry offers faster look at the edges of brain tumors

AI 导读

普渡大学与 Mayo Clinic 研究人员在 PNAS 发表研究,展示一种利用串联质谱法在约 3 分钟内分析脑组织样本以映射胶质瘤边缘的技术。该研究对 86 个人类脑组织样本进行测定,发现内源性代谢物比值可高置信度地区分肿瘤与非肿瘤组织,并分类肿瘤亚型及突变状态。团队计划开展涉及 50 多名患者的术中测试,以推动该技术向临床试验阶段发展。

正文
Mass spectrometry offers faster look at the edges of brain tumors
Brain cancer margins can be especially difficult to map. Using mass spectrometry, researchers from Purdue University and the Mayo Clinic can map margins in resected tissue in a three-minute measurement as seen in the illustration. Credit: Mahdiyeh Shahi/Purdue University

Glioma brain tumors are diffuse, so surgeons usually cannot excise all of the cancer during surgery. Currently, surgeons remove as much of the tumor as they can and then analyze the tumor's borders after surgery.

Researchers at Purdue University have developed a new method in which mass spectrometry could be used during surgery to evaluate tissue. This information could help guide the surgical team's decisions, increasing the amount of cancerous tissue they are able to remove and improving the patient's outcomes.

The research, which was published in PNAS, was led by Mahdiyeh Shahi, a former graduate student at Purdue University, and R. Graham Cooks, the Henry Bohn Hass Distinguished Professor of Chemistry in the James Tarpo Jr. and Margaret Tarpo Department of Chemistry at Purdue.

Shahi is now a clinical chemistry postdoctoral fellow at the University of Minnesota Medical School. Shahi and Cooks collaborated with brain surgeon Dr. Alfredo Quiñones-Hinojosa of the Mayo Clinic; Quiñones-Hinojosa's postdoctoral fellow, Loizos Michaelides; and others from Mayo to develop and test this mass spectrometry method.

Detecting cancer at the tumor margins

Gliomas are highly infiltrative and deadly brain tumors with complex molecular characteristics that complicate diagnosis and treatment. Brain surgery is one of the most important treatments for glioma and can strongly affect a patient's prognosis and survival.

Because glioma cells can spread into nearby healthy brain tissue, particularly at the tumor margins, they are difficult to detect using conventional technologies available in the operating room. Tumor tissue that remains in the brain after surgery can contribute to recurrence and make further treatment more challenging.

"The information we are getting is currently not available under standard-of-care procedures," said Shahi.

"If our diagnostic method were to be approved, it would provide actionable molecular information during surgery. This information is currently not available on the timescale (some hours) of the surgery.

"This information could directly influence treatment, including the extent of tumor resection, although the final surgical decision would be made by the surgeon based on the overall clinical context rather than the mass spectrometry results alone. It could also help guide the selection of targeted therapies."

Molecular measurements in roughly 3 minutes

During brain tumor surgery, a small number of samples are taken from a surgeon-defined position in the brain for pathology. In this study, fractions of such samples were transferred onto the plunger of a hypodermic needle. Scientists would then spray a solution and use tandem mass spectrometry to measure the ratio of signals for multiple pairs of endogenous compounds in the brain, a process that takes roughly three minutes.

"The study used 86 human brain samples, and the researchers showed that ratios of endogenous metabolites in brain tissue can distinguish glioma from nontumor tissue with high confidence," said Cooks.

"It can also classify tumor subtypes and mutation status. The simple ambient ionization mass spectrometry approach enables fast, clinically compatible analysis with the potential to improve margin assessment and enhance patient outcomes."

Mass spectrometry is an analytical laboratory technique that measures the mass-to-charge ratio of ionized molecules to identify and quantify complex chemical compounds.

"The mass spectrometry technology we used was invented at Purdue," said Cooks. "The method was based on ambient ionization making ions from molecules in the open environment. This allows molecular measurements to be made in situ. The first such method was described in 2004 and has since been commercialized and widely used.

"The new method used in this study—syringe touch spray—uses an ordinary hypodermic to take a sample from the patient and perform mass spectrometry analysis."

The samples analyzed in this study were taken using MRI-guided precision surgery. The tissue samples were characterized by standard methods, which provide molecular information only after surgery.

Further testing needed during surgery

Now that this technique has been tested on 86 human samples, the team will explore the next steps toward using it in surgery and diagnosis. A similar study involving 50-plus patients will need to be undertaken in which the technique is used during surgery. According to Cooks, this would pave the way for a clinical trial to be proposed.

"In previous work, our measurements have been made in the hospital, during surgery," said Cooks. "In this case, we recorded the mass spectrometry remotely and compared the results with the available clinical information. The very simple and quick measurement has high discriminating power, distinguishing diseased from nondiseased tissue as well as providing information on tumor grade and mutation status.

"This technology would not replace the current standard of care during brain tumor surgery. Instead, it could provide surgeons with molecular information that is not currently available in the operating room, helping to guide surgical decisions during tumor removal, particularly at the tumor margins."

The research team included Shahi and Cooks, along with Quiñones-Hinojosa, a professor of neurosurgery at Mayo Clinic in Jacksonville, Florida; Michaelides; Diogo Moniz Garcia, a former postdoctoral fellow at Mayo Clinic and current PGY3 neurosurgery resident at Washington University in St. Louis; and Aleeshba N. Basil of the Mayo Clinic.

Publication details

Mahdiyeh Shahi et al, Metabolite ratiomics: Rapid diagnosis and classification of gliomas for intraoperative application during brain surgery, Proceedings of the National Academy of Sciences (2026). DOI: 10.1073/pnas.2616216123

Journal information: Proceedings of the National Academy of Sciences

Who's behind this story?

Sadie Harley

Sadie Harley

BSc Life Sciences & Ecology. Microbiology lab background with pharmaceutical news experience in oil, gas, and renewable industries. Full profile →

Robert Egan

Robert Egan

Bachelor's in mathematical biology, Master's in creative writing. Well-traveled with unique perspectives on science and language. Full profile →

Citation: Mass spectrometry offers faster look at the edges of brain tumors (2026, October 2) retrieved 2 October 2026 from https://medicalxpress.com/news/2026-10-mass-spectrometry-faster-edges-brain.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

来源:Medical Xpress · medicalxpress.com